Published in:
01-09-2016
Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations
Authors:
Kerstin Wolk, Robert Sabat
Published in:
Reviews in Endocrine and Metabolic Disorders
|
Issue 3/2016
Login to get access
Abstract
Psoriasis is a chronic inflammatory skin disease most common in Europe, North America, and Australia. The etiology and pathomechanisms underlying the evolution and persistence of the skin alterations are increasingly being understood and have led to the development of effective anti-psoriatic therapies. Apart from the skin manifestations, psoriasis is associated with the metabolic syndrome (MetS), known to increase the risk of type 2 diabetes mellitus and cardiovascular disorders. Research of the last years demonstrated a dysregulated adipokine balance as an important link between inflammation, MetS, and consequential disorders. This article describes selected adipokines and their potential role in both metabolic comorbidity and skin inflammation in psoriasis.